From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Does Vitamin D Supplementation Prevent Fractures?

Previous studies have yielded conflicting results on the effectiveness of oral vitamin D supplementation in preventing fractures in older patients. These investigators conducted a meta-analysis of seven randomized controlled trials of vitamin D supplementation (with or without calcium) versus either calcium alone or placebo. The trials included 9820 subjects (mean age, 79; 68% women) who were followed for nonvertebral fractures for 18 to 60 months; 9294 subjects were assessed specifically for hip fractures.

Low-dose vitamin D (400 IU daily) had no effect on risk for hip fractures, but high-dose supplementation (700–800 IU daily) was associated with a 26% relative risk reduction and a 2% absolute risk reduction (number needed to treat [NNT], 45). For all nonvertebral fractures, high-dose supplementation was associated with a 23% relative risk reduction and a 4% absolute risk reduction (NNT, 27). Again, low-dose supplementation provided no benefit.

Interestingly, a new clinical trial is at odds with this meta-analysis. Investigators in the U.K. conducted a randomized trial of 3314 community-dwelling older women (age, ≥70) who reported at least one of the following risk factors: previous fracture, low body weight (<58 kg), fair or poor health, cigarette use, or maternal history of fracture. The intervention group received daily supplements of calcium (1000 mg) and cholecalciferol (vitamin D3; 800 IU), whereas the control group received printed information. Fractures were self-reported and confirmed by physicians. During a median follow-up of 24 months, the incidence of all fractures was similar in the two groups (about 4.5%).

Comment: Important differences between trials — in terms of patient populations, vitamin D doses, enrollees’ initial vitamin D status, and calcium intake — probably have led to conflicting results among clinical trials. However, the overall body of evidence suggests that vitamin D plus calcium offers benefit to some patients. At the time of publication, the full text of the BMJ article was available free of charge.

— Thomas L. Schwenk, MD, and Keith I. Marton, MD

Published in Journal Watch General Medicine June 3, 2005

Citation(s):

Bischoff-Ferrari HA et al. Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. JAMA 2005 May 11; 293:2257-64.

Porthouse J et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005 Apr 30; 330:1003-5.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2005. Massachusetts Medical Society. All rights reserved.